SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced that Dr. Michael Fons, Vice President, Corporate Development, has been invited to present an overview of the company’s technology and products at the 2007 Annual Meeting of the American Association of Pharmaceutical Scientists being held at the San Diego Convention Center in San Diego, California. The presentation, scheduled for 2 p.m. PST on Wednesday, November 14th, is entitled “Devices Used for Nucleic Acid Delivery.”
